In this article the author discusses non-alcoholic fatty liver disease (NAFLD). The author states that NAFLD is a primary hepatic disease that treated more severe entity like nonalcoholic steatohepatitis (NASH). The author further discusses the diagnosis of potential NAFLD-associated diseases and adequate evaluation of cardio-vascular risk.